# Pulmonary Tuberculosis: Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pulmonary-tuberculosis-developing-drugs-for-treatment/8b46de55-ddca-4887-a2ad-5d46be5633aa

> FDA guidance document: Pulmonary Tuberculosis: Developing Drugs for Treatment. Issue date: December 14, 2022. Get complete insights and analysis.

---

## Details

- Title: Pulmonary Tuberculosis: Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-12-14
- Comment Close Date: 2023-02-13
- Last Changed: 2022-12-19
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-D-1319">FDA-2013-D-1319</a>

## Related Documents

- [Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention](https://www.globalkeysolutions.net/guidances/guidance-document/clostridioides-difficile-infection-developing-drugs-for-treatment-reduction-of-recurrence-and-prevention/b0e5f4fd-4c99-48d2-ad08-77dfb3fc2cc2)
- [Statistical Approaches to Establishing Bioequivalence](https://www.globalkeysolutions.net/guidances/guidance-document/statistical-approaches-to-establishing-bioequivalence/ecbc1c62-e39f-4980-b654-baa7788c2171)
- [Gastroparesis: Clinical Evaluation of Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/gastroparesis-clinical-evaluation-of-drugs-for-treatment-guidance-for-industry/4b7bc445-8e11-4ce8-a6d6-3439f06daab5)